Journal of Korean Biological Nursing Science

Korean society of Biological Nursing Science (한국기초간호학회)
권호 표지
DOI QR코드

DOI QR Code

Factors that Affect Remission of Chemotherapy-Induced Peripheral Neuropathy Symptoms: Short-Term Prospective Study

  • Received : 2022.04.30
  • Accepted : 2022.05.27
  • Published : 2022.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Patients experiencing chemotherapy-induced peripheral neuropathy (CIPN) apply various palliative care as well as drugs in their daily life to alleviate symptoms. There is a need to identify the influence of these efforts and patients' psychosocial status on the relief of CIPN symptoms. This short-term prospective study investigated how prescription drugs, non-pharmacological behaviors (exercise, massage, and heat therapy), and psychological states (social support, depression, and anxiety) affected CIPN symptoms. Methods: Participants scheduled to receive postoperative platinum or taxane-based chemotherapy were enrolled consecutively. CIPN was measured with the Neurotoxicity-12 subscale of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity-12 instrument. Data were collected three times during the 4 or 5 cycles of chemotherapy. Results: At the end of the 2nd chemotherapy cycle, 93.1% of participants reported CIPN symptoms. Multiple regression analyses showed that a heat therapy (β= -.34, p< .001), massage (β= -.21, p= .012), and walking 5 times or more per week (β= -.26, p= .021) provided relieve for CIPN symptoms. Depression (β= .19, p= .027) significantly exacerbated CIPN symptoms. Conclusion: These results suggested that a comprehensive management program that includes walking, heat therapy, massage, and mood therapy should be encouraged. Moreover, patients should be educated at chemotherapy initiation to understand appropriate interventions that can relieve CIPN symptoms.

Keywords

References

  1. National Cancer Information Center. Cancer prevalence [internet]. Goyang: National Cancer Information Center; 2017 [cited 2017 Oct 10]. Available from https://www.cancer.go.kr/lay1/S1T654C655/contents.do
  2. Kim H, Park H. Chemotherapy induced peripheral neuropathy, sleep and quality of life among patients with gastric cancer receiving chemotherapy. Journal of Korean Academy of Fundamental Nursing. 2018;25(3):176-184. https://doi.org/10.7739/jkafn.2018.25.3.176
  3. Tofthagen C, Visovsky CM, Hopgood R. Chemotherapy-induced peripheral neuropathy: an algorithm to guide nursing management. Clinical Journal of Oncology Nursing. 2013;17(2):138-144. https://doi.org/10.1188/13.CJON.138-144
  4. Banach M, Juranek JK, Zygulska AL. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers. Brain and Behavior. 2017;7(1):e00558. https://doi.org/10.1002/brb3.558
  5. Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461-2470. https://doi.org/10.1016/j.pain.2014.09.020
  6. Bakitas MA. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Nursing Research. 2007;56(5):323-331. https://doi.org/10.1097/01.Nnr.0000289503.22414.79
  7. Kim KY, Lee SH, Oh PJ. Chemotherapy-induced peripheral neuropathy and depression in cancer patients. Asian Oncology Nursing. 2015;15(3):149-155. https://doi.org/10.5388/aon.2015.15.3.149
  8. Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: the pathways study. Journal of the National Cancer Institute. 2016;109(2):djw206. https://doi.org/10.1093/jnci/djw206
  9. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Seminars in Oncology. 2006;33(1):15-49. https://doi.org/10.1053/j.seminoncol.2005.12.010
  10. Hershman DL, Lacchetti C, Dworkin RH, Smith EML, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. Journal of Clinical Oncology. 2014;32(18):1941-1967. https://doi.org/10.1200/jco.2013.54.0914
  11. Mols F, Beijers AJM, Vreugdenhil G, Verhulst A, Schep G, Husson O. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry. Journal of Cancer Survivorship. 2015;9(3):512-522. https://doi.org/10.1007/s11764-015-0427-1
  12. Tofthagen C, Visovsky C, Beckstead J, Loy I, Eckelman E. Results of a strength and balance training pilot study for colorectal cancer survivors with peripheral neuropathy caused by oxaliplatin. Rehabilitation Oncology. 2014;32(4):38-44.
  13. Garcia MK, Cohen L, Guo Y, Zhou Y, You B, Chiang J, et al. Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study. Journal of Hematology & Oncology. 2014;7(1):41. https://doi.org/10.1186/1756-8722-7-41
  14. Park JH, Lee JS, Cho CK, Yoo HS. Electroacupuncture for the treatment of the chemotherapy-induced peripheral neuropathy in breast cancer patient: a case report. Korean Academy of Traditional Oncology. 2015;20 (1):1-9. https://doi.org/10.15432/JKTO.2015.20.1.001
  15. Noh GO, Park KS. Effects of aroma self-foot reflexology on peripheral neuropathy, peripheral skin temperature, anxiety, and depression in gynaecologic cancer patients undergoing chemotherapy: a randomised controlled trial. European Journal of Oncology Nursing. 2019;42:82-89. https://doi.org/https://doi.org/10.1016/j.ejon.2019.08.007
  16. Kim SY, Jun EY. Effects of foot bath therapy on the symptom intensity, distress, and interference with usual activities due to chemotherapy-induced peripheral neuropathy in patients with metastatic and recurrent cancer. Journal of Korean Academic Society of Home Health Care Nursing. 2017;24(2):189-199. https://doi.org/10.22705/JKASHCN.2017.24.2.189
  17. Oh PJ, Kim YL. Effectiveness of non-pharmacologic interventions in chemotherapy induced peripheral neuropathy: a systematic review and meta-analysis. Journal of Korean Academy of Nursing. 2018;48(2):123-142. https://doi.org/10.4040/jkan.2018.2.123
  18. Bulls H, Hoogland A, Chahal N, Small B, Gonzalez B, Kennedy B, et al. Chemotherapy-induced peripheral neuropathy in gynecologic cancer patients: risk factors and functional impact. The Journal of Pain. 2018;19(3):S101-S102. https://doi.org/10.1016/j.jpain.2017.12.231
  19. Han SS, Han SS, Han JW. The influences of depression, anxiety, social support and knowledge of anticancer drugs on the chemotherapy-induced peripheral neuropathy among colorectal cancer patients receiving oxaliplatin. Journal of Korean Clinical Nursing Research. 2013;19(2):298-308. https://doi.org/10.22650/JKCNR.2013.19.2.298
  20. Mazilu L, Stanculeanu DL, Gheorghe AD, Voinea F, Suceveanu AP, Pituru S, et al. Incidence of chemotherapy-induced peripheral neuropathy in cancer patients in clinical practice. FARMACIA. 2019;67(3):472-476. https://doi.org/10.31925/farmacia.2019.3.14
  21. Calhoun EA, Welshman EE, Chang CH, Lurain JR, Fishman DA, Hunt TL, et al. Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (Fact/ GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. International Journal of Gynecological Cancer. 2003;13:741-748. http://dx.doi.org/10.1136/ijgc-00009577-200311000-00003
  22. Sherbourne CD, Stewart AL. The MOS social support survey. Social Science & Medicine. 1991;32(6): 705-714. https://doi.org/10.1016/0277-9536(91)90150-b
  23. Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups. Journal of Korean Neuropsychatric Association. 1999;38(2):289-296.
  24. Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treatment Reviews. 2014;40(7):872-882. https://doi.org/10.1016/j.ctrv.2014.04.004
  25. Cohen J, Cohen P, West S, Aiken L. Applied multiple regression/correlation analysis for the behavioral sciences. 3rd ed. London: Lawrence Erlbaum Associates Pulishers; 2002. p. 64-100.
  26. Field A. Discovering statistics using SPSS. 2nd ed. London: Sage Publications; 2005. p. 143-217.
  27. Argyriou AA, Cavaletti G, Briani C, Velasco R, Bruna J, Campagnolo M, et al. Clinical pattern and associations of oxaliplatin acute neurotoxicity. Cancer. 2013;119(2):438-444. https://doi.org/10.1002/cncr.27732
  28. McRee LD, Noble S, Pasvogel A. Using massage and music therapy to improve postoperative outcomes. AORN Journal, 2003;78(3):433-447. https://doi.org/https://doi.org/10.1016/S0001-2092(06)60754-0
  29. Streckmann F, Zopf EM, Lehmann HC, May K, Rizza J, Zimmer P, et al. Exercise intervention sudies in ptients with pripheral nuropathy: a systematic review. Sports Medicine. 2014;44(9):1289-1304. https://doi.org/10.1007/s40279-014-0207-5
  30. Oh PJ, Choi ES, Lee J. The experience of chemotherapy-induced peripheral neuropathy in people with cancer. Asian Oncology Nursing. 2019;19(2):81-89. https://doi.org/10.5388/aon.2019.19.2.81